{Summary}
{Click on Image to Enlarge}
___
Event description
The Bundibugyo virus disease (BVD) outbreak in the Democratic Republic of the Congo continues at a high and sustained level of transmission.
During epidemiological week 46 (9 – 15 November 2026), 442 confirmed cases and 239 confirmed deaths were reported, compared with 458 cases and 228 deaths in week 45; the national seven-day average has remained between 62 and 65 cases per day, and a new health zone, Watsa in Haut-Uélé, reported its first confirmed cases.
Over three epidemiological weeks (weeks 44 – 46 compared with weeks 41 – 43), reported cases decreased by 6.7% and deaths by 4.6%, with a decline in Ituri partly offset by continued intense transmission in Nord-Kivu, where Beni remains the health zone with the most cases, and by rising incidence in Mangala, Mambasa and Mutwanga.
Deaths in treatment centres increased in week 46 and the proportion of deaths occurring in the community fell to 59% (142 of 239), its lowest weekly level since August.
In Kenya, the last patient was discharged on 11 November, and all contacts have completed their follow-up; the 42-day countdown is under way, and the event has not yet been declared over.
In Nigeria, all 62 contacts completed their 21-day follow-up on 13 November and no secondary case was identified; surveillance continues in both countries.
Additionally, Nigeria started the 42 days countdown on 27 Oct after the case was medically evacuated to Switzerland on the 26 October 2026.
In the Democratic Republic of the Congo, insecurity in Beni, Mabalako and Bafwasende, strikes over unpaid salaries in several provinces and community resistance to safe burials continue to constrain surveillance and response operations.
Democratic Republic of the Congo
As of 15 November 2026, the BVD outbreak in the Democratic Republic of the Congo has affected 68 health zones and 248 health areas across eight provinces.
One new health zone, Watsa in Haut-Uélé, was affected during the reporting period (two confirmed cases reported on 11 November and seven on 13 November).
Since External Situation Report #26, (data as of 7 November), an additional 512 confirmed cases and 270 confirmed deaths have been reported between 8 and 15 November, of which 442 cases and 239 deaths during epidemiological week 46 (9 – 15 November).
The cumulative total is 11 432 confirmed cases, including 5 593 confirmed deaths [crude case fatality ratio (CFR) 48.9%].
Among cases with a documented outcome (5 593 deaths and 3 109 recoveries), the case fatality ratio is 64.3%; the outcome of the remaining 2 730 cases is still pending or not yet recorded.
Transmission remains highly heterogeneous across affected areas. Ituri continues to account for the largest proportion of cumulative confirmed cases (68.9%) and accounted for 227 of the 442 cases reported in week 46 (51.4%), while Nord-Kivu (25.3% of cumulative cases; CFR 55.4%) accounted for 169 (38.2%). Transmission persists at lower levels in Haut-Uélé (35 cases; 7.9%), Tshopo (10; 2.3%) and Nord-Ubangi (one case).
National daily incidence rose steadily from May to its highest levels in late July and mid-August, declined through late September and has fluctuated at a high plateau since early October. The seven-day moving average ranged between 62 and 65 confirmed cases per day during week 46 (63.1 on 15 November, compared with 65.4 on 8 November), well below the mid-August peak of 94 but with no downward trend over the last six weeks. Provincial trends diverged.
Ituri reported 227 cases in week 46 compared with 223 in week 45 (seven- day average of 32 cases per day on 15 November), with Mandima, Bunia, Mangala and Mambasa reporting the most cases, while Nord-Kivu reported 169 cases compared with 202 (24 cases per day on 15 November, down from 29 on 8 November), Beni still reporting the largest numbers in the province.
Haut-Uélé reported 35 cases compared with 24 (13 of them on 13 November, seven in the newly affected Watsa Health Zone), Tshopo 10 compared with six, and Nord- Ubangi one case in Wapinda. Bas-Uélé, Sud-Kivu and SudUbangi have reported no case in the last 21 days (Figures 1 and 2).
By week of symptom onset (Figure 3), confirmed cases recorded in the DHIS2 line list peaked between late July and mid-August, remained above 400 per week until mid September and have declined gradually since, to 370 in week 43 and 306 in week 44; weeks 44 to 46 are still incomplete because of the delay between symptom onset and reporting (median five days, 90th percentile 14 days).
{Click on Image to Enlarge}
___
(...)
Trend Analysis (21-day comparison):
During the most recent three epidemiological weeks (weeks 44 – 46, 26 October – 15 November 2026), a total of 1 369 confirmed cases were reported nationally, compared with 1 468 during the preceding 21 days (weeks 41 – 43, 5 – 25 October), a decrease of 99 cases (−6.7%).
Cases in Ituri decreased from 762 to 670 (−12.1%), accounting for 48.9% of national cases during the latest period, and in Nord-Kivu from 590 to 580 (−1.7%), accounting for 42.4%. Haut-Uélé increased from 77 to 90 cases (+16.9%; 6.6% of national cases) and Nord-Ubangi from three to four, while Tshopo decreased from 33 to 25 (−24.2%). Bas-Uélé, which reported three cases in the preceding period, reported none; SudKivu and Sud-Ubangi reported no case in either period. These weekly and three-week figures are sums of the daily counts published in the national sitreps, as on the COUSP dashboard; the corresponding differences in cumulative counts (1 372 and 1 457 cases) differ slightly because retrospectively added cases enter the cumulative totals only.
During the same period, 706 confirmed deaths were reported nationally, compared with 740 during weeks 41 – 43 (−4.6%). Deaths decreased from 402 to 355 (−11.7%) in Ituri, from 38 to 35 in Haut-Uélé and from 10 to eight in Tshopo, but increased from 289 to 308 (+6.6%) in Nord-Kivu, which now accounts for 43.6% of newly reported deaths (39.1% in the preceding period) against 50.3% for Ituri. Nord-Ubangi, which reported one death in the preceding period, reported none. In Nord-Kivu, deaths rose while cases fell slightly, consistent with the province's higher case fatality ratio (55.4%).
(...)
Transmission remained active in more than two-thirds of the health zones affected since the start of the outbreak. Of the 68 health zones affected to date, 48 (70.6%) in five provinces reported at least one new confirmed case during weeks 44 – 46 (26 October – 15 November): 21 in Ituri, 14 in Nord-Kivu, six in Haut-Uélé, five in Tshopo and two in NordUbangi. The comparison between the two 21 days periods covers the 54 health zones that reported at least one case in either period: incidence increased in 22, decreased in 28 and was unchanged in four (Mahagi and Nyankunde in Ituri, Alimbongo in Nord-Kivu and Wapinda in Nord-Ubangi); the remaining 14 zones reported no case in either period.
The largest absolute increase occurred in Beni, Nord-Kivu (228 to 273 cases; +19.7%), followed by Mutwanga, Nord-Kivu (28 to 71; +153.6%), Mangala, Ituri (22 to 63; +186.4%), Mambasa, Ituri (46 to 76; +65.2%), Oicha, Nord-Kivu (43 to 57; +32.6%), Mongbwalu, Ituri (10 to 22), Isiro, Haut-Uélé (7 to 18), Pawa, Haut-Uélé (19 to 29) and Masereka, Nord-Kivu (7 to 16). Watsa in Haut-Uélé (nine cases), Kilo (five), Drodro and Kambala (one each) in Ituri and Yakoma in Nord-Ubangi (four) reported cases after none in the preceding period (Figure 5). Conversely, the largest decreases were observed in Mandima (257 to 202), Rwampara (71 to 48), Bunia (170 to 149), Nia-Nia (27 to 8), Aru (17 to 1) and Komanda (18 to 2) in Ituri; Butembo (52 to 23), Katwa (61 to 36) and Mabalako (54 to 34) in Nord-Kivu; and Wamba (47 to 23) in HautUélé. In week 46, Beni (71 cases), Mandima (65) and Bunia (51) reported the most cases, followed by Mangala (31), Oicha (25) and Mambasa (24). Zone-level figures are differences in cumulative confirmed cases between SitReps N°143, N°164 and N°185 and reconcile to the national totals.
There were 20 health zones without a new case during weeks 44 – 46: Adja, Ariwara, Aungba, Boga, Damas, Gety and Logo in Ituri; Goma, Kayna and Manguredjipa in Nord-Kivu; Dungu and Gombari in Haut-Uélé; Lubunga and WanieRukula in Tshopo; Miti-Murhesa in Sud-Kivu; Buta, Dakwa, Ganga and Viadana in Bas-Uélé; and Bulu in Sud-Ubangi. Six of them (Damas, Gety and Logo in Ituri, Manguredjipa in Nord-Kivu, and Dakwa and Ganga in Bas-Uélé) had reported cases during weeks 41 – 43.
(...)
Weekly confirmed deaths (Figure 7) have fluctuated between 220 and 290 since mid-October: 286 in week 43 (19 – 25 October), 239 in week 44, 228 in week 45 and 239 in week 46 (9 – 15 November), an increase of 4.8% over the preceding week. Community deaths decreased from 149 in week 45 to 142 in week 46 while deaths in treatment facilities rose from 79 to 97, so that the proportion of deaths occurring in the community fell from 65.4% to 59.4%, the lowest weekly share since the week of 17 – 23 August (Figure 8). On 15 November, 18 of the 25 confirmed deaths (72%) occurred in the community. Although the shift in week 46 suggests that more patients reached treatment facilities before dying, three in five confirmed deaths still occur outside treatment facilities, and the increase in deaths in treatment centres also points to late presentation.
(...)
Kenya
Since the previous report, Kenya has reported no new confirmed case of BVD. The cumulative total remains nine confirmed cases, including two deaths (CFR 22.2%), all belonging to a single chain of transmission linked to the imported index case; the last confirmed case was reported on 19 October 2026.
On 11 November 2026, the Ministry of Health announced the discharge of the last patient under treatment, the seventh survivor, after two consecutive negative tests, and the final 11 contacts completed their 21-day monitoring and were released from quarantine on the same day. For the first time since the first case was confirmed, Kenya has no patient under treatment and no contact under follow-up.
The 42-day countdown started on 12 November 2026; the end of the event will be declared by the Government if no new case is detected during that period. Surveillance, screening at points of entry and survivor follow-up continue.
(...)
Nigeria
Nigeria has reported a single confirmed case of BVD, confirmed on 20 October 2026 in the Federal Capital Territory, Abuja, in a traveller from Uganda. The patient was medically evacuated to Switzerland on 26 October and discharged from the Geneva University Hospitals on 11 November 2026 after full recovery; the 42-day countdown is counted from 27 October, the day after the evacuation. No secondary case has been identified. On 13 November 2026, the Nigeria Centre for Disease Control and Prevention (NCDC) announced that all 62 contacts of the index case had completed their 21-day follow-up; 13 contacts who developed fever or non-specific symptoms during monitoring tested negative, as did seven suspected cases reported from Adamawa, Borno, Ekiti, Lagos and Rivers states over the preceding three weeks.
The 62 contacts include the companion evacuated with the patient, whose follow-up in Switzerland was due to end on 16 November according to the Swiss IHR National Focal Point. The Emergency Operations Centre remains activated and surveillance continues; the completion of contact monitoring does not constitute a declaration of the end of the event, which will follow WHO criteria.
Two lessons stand out from this event: the rapid activation of the incident management system and of response activities once the case was notified and confirmed, and the 12-day interval between symptom onset and notification, eight days of which were spent in a private health facility, which underlines the need for a high index of suspicion among clinicians for travellers from affected areas.
(...)
Situation interpretation
The BVD outbreak in the Democratic Republic of the Congo remains at a critical juncture six months after its declaration.
Transmission is broadly stable at a high level: 442 confirmed cases and 239 deaths were reported in epidemiological week 46, the national seven-day average has held between 61 and 76 cases per day since the beginning of October, and the three-week totals fell marginally, from 1 468 to 1 369 cases (−6.7%) and from 740 to 706 deaths (−4.6%).
The decrease is driven by Ituri, where Mandima, Bunia and Rwampara reported fewer cases, while Mangala and Mambasa in Ituri and Mutwanga and Oicha in Nord-Kivu are intensifying, Beni remains the largest focus, Haut-Uélé reported a new health zone (Watsa), and sporadic transmission continued in Tshopo and Nord-Ubangi.
The response is still not reaching the performance required to interrupt transmission: only half of investigated suspected cases are isolated within 24 hours, close to one in six contacts is not seen each day, more than 1 000 contacts have been lost to follow-up, and three in five deaths still occur in the community, although the share of community deaths fell in week 46 and safe burial refusals decreased.
Insecurity in Beni, Mabalako and Bafwasende, strikes over unpaid salaries and shortages of vaccine doses in Nord-Kivu further constrain operations.
In Kenya, where eight secondary cases occurred in a single chain, all contacts have completed follow-up and the 42-day countdown is under way; in Nigeria, contact monitoring 18 ended on 13 November with no secondary case identified.
Neither event has been declared over and surveillance continues in both countries. Priorities remain reinforcing response capacity in the most active health zones of Nord-Kivu (Beni, Mutwanga, Oicha) and Ituri (Mandima, Bunia, Mangala, Mambasa), investigating the new focus in Watsa, improving the timeliness of isolation of suspected cases and the completeness of contact follow- up, maintaining safe burial performance, securing vaccine supply for frontline workers, and maintaining cross-border surveillance and information sharing.
Source: World Health Organization, Regional Office for Africa, https://www.afro.who.int/countries/kenya/publication/ebola-bundibugyo-virus-disease-outbreak-democratic-republic-congo-uganda-weekly-external-situation
____
















